L-Carnitine Mitigates Oxidative Stress and Disorganization of Cytoskeleton Intermediate Filaments in Cisplatin-Induced Hepato-Renal Toxicity in Rats

Abstract

Cisplatin (CP) is one of the most active medications in cancer treatment and has some adverse effects such as hepatotoxicity and nephrotoxicity. The present research was planned to determine the protective effects of L-carnitine (LC) against CP-induced hepatorenal oxidative stress in rats, via investigating of some serum biochemical and tissue oxidative/antioxidant parameters, histological alterations, and immunohistochemical expressions of two different intermediate filaments (IFs) proteins; vimentin (VIM) and cytokeratin 18 (CK18). Twenty-eight rats were divided into four groups (7 rats each). Groups I and II were orally administered saline and LC (100 mg/kg body weight), respectively, once daily for 30 consecutive days. Group III received saline orally once daily and a single dose of CP on the 27th day of the experiment [7.5 mg/kg, intraperitoneal (IP)]. Group IV received both LC and CP. Injection of CP significantly (P ≤ 0.05) increased serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) activities and creatinine and urea levels, while serum total protein, albumin, and globulin concentrations significantly (P ≤ 0.05) decreased. In addition, CP induced a dramatic increase in the Malondialdehyde (MDA) level along with a substantial decrease in reduced glutathione (GSH) and catalase (CAT) in the hepato-renal tissues. Histologically, both liver and kidney of the CP treated group revealed marked degenerative changes. Moreover, overexpression of both VIM and CK18 in hepato-renal tissues were noted after CP injection. On the other hand, the administration of LC in the CP injected group (Group IV) restored the biochemical parameters, histological, and immunohistochemical pictures toward the normalcy. In conclusion, LC may be supplemented for chemotherapy with CP to ameliorate its oxidative stress and restore

Ameliorative effect of L-carnitine on lambda-cyhalothrin-induced anatomical and reproductive aberrations in albino mice

“…L-carnitine an innate component of mammalian tissue synthesized from lysine and methionine essential amino acids. It is derived from dietary sources (75%) and endogenous biosynthesis (25%) mainly in the liver and kidney, is a necessary factor for the utilization of long-chain fatty acids to produce energy in mitochondria ( Elkomy et al, 2020 , Jin et al, 2019 , Sallam et al, 2020 ). It has been shown to function as an antioxidant that scavenges reactive oxygen species (ROS); so could prevent mitochondrial oxidative stress-induced by mitochondrial damage and apoptosis in different cell types, and also elicits stabilizing effect on damaged cell membranes ( Dokmeci et al, 2006 , Edres et al, 2018 , Ghonem et al, 2018 , Sallam et al, 2020 , Sarica et al, 2007 ).…”

Rosmarinic acid relieves cisplatin‐induced ovary toxicity in female mice via suppression of oxidative stress and inflammation

“…[6,7] CIS induces the cytotoxic effect via association with the DNA by facilitating a covalent adduct between the platinum compound and purine bases, which triggers apoptosis and G2 cell cycle arrest. [10][11][12] Apart from its antitumor effect, CIS has numerous toxic and adverse effects, which influence the gastrointestinal, hematological, and neurological systems. However, CIS administration has been accompanied by nephrotoxicity, cardiotoxicity, hepatotoxicity, and ovarian toxicity.…”

l-Carnitine Mitigates Trazadone Induced Rat Cardiotoxicity Mediated via Modulation of Autophagy and Oxidative Stress

“…Clinical studies have shown, l -carnitine supplementation can enhance myocardial fat metabolism due to the increased demand for free fatty acids and their metabolites and thus creates a beneficial effect on myocardial function [ 31 , 32 ]. Besides, therapeutic potentials of l -carnitine have been investigated in many rat models, for instances, in tilmicosin-induced cardiotoxicity [ 33 ], and imatinib-induced cardiotoxicity [ 34 ].…”